Talk:Oncolytics Biotech

Medicine: Hematology-oncology Low‑importance

	Medicine portal This article is within the scope of WikiProject Medicine, which recommends that medicine-related articles follow the Manual of Style for medicine-related articles and that biomedical information in any article use high-quality medical sources. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.MedicineWikipedia:WikiProject MedicineTemplate:WikiProject Medicinemedicine articles
Low	This article has been rated as Low-importance on the project's importance scale.
	This article is supported by the Hematology-oncology task force.

[Untitled][edit]

I think that the tag that the article that it appears to be written as an advertisement should be removed.

The company has only one experimental drug under development and no products licenced for sale, so it can be reasonably expected to go out of business in a hurry if the clinical trials of its drug come out badly. But until that happens one shouldn't expect to have much negative to say. (Indeed, they would have quite a lot of trouble raising money for expensive medical studies and getting approval for testing in humans if there was existing signficant detracting information.)

173.32.146.126 (talk) 17:28, 10 May 2012 (UTC)[reply]